New York
How In re Caremark International Inc. Derivative Litigation applies in New York: state-specific rules, key cases, and bar exam notes for Corporate Law.
New York law follows the principles articulated in Caremark, focusing on directors' duty to oversee corporate activities and ensure compliance with applicable laws. This form of oversight duty becomes particularly relevant in derivative actions where shareholder actions are based on directors' alleged failings in managing company risks.
In New York, directors must establish a system of controls and procedures sufficient to enable compliance with applicable laws and policies. Directors can only be shielded from liability if they demonstrate a good faith effort to put such systems in place and actively monitor their efficacy.
The Delaware Court confirmed that a failure to act in good faith could lead to liability under Caremark standards when directors ignore red flags relevant to corporate oversight.
New York courts held that a failure to monitor system is a breach of the duty of good faith, aligning with the principles established in Caremark.
The court emphasized that to meet the Caremark standard, the board must engage in good faith oversight of the corporation's compliance practices.
While federal law emphasizes the business judgment rule, New York's approach aligns closely with Caremark's principles by mandating directors to actively oversee compliance systems. However, New York also places greater emphasis on good faith, expanding the scope for potential liability in cases of negligent oversight.
Caremark's principles are essential for understanding directors' duties in New York and are likely to be tested on the New York Bar Exam, particularly in the context of derivative suits and corporate governance issues.